Inflammatory Cytokines and the Risk of Cardiovascular Complications in Type 2 Diabetes

Table 1

Cardiovascular metabolite profiles for diabetic (𝑛=24) and control subjects (𝑛=15). Mean percentage of each subpopulation ± SEM shown.

	All type 2 diabetes (AD); (𝑛=40)	Diabetes without CHD; (𝑛=24)	Diabetes with CHD; (𝑛=16)	Healthy control subjects; (𝑛=30)
Sex (M/F)	25/15	16/8	9/7	19/11
Age (years)	50.3±21.4	49.8±1.67	51.9±2.1	50.1±1.7
BMI (Kg/m^2)	29.6±1.39^∗	29.4±0.87^∗	30.44±1.4^∗	27.4±3.7
HbA1c (mmol/L)	7.98±0.63^∗	8.20±0.25^∗	8.7±0.46^∗	5.6±0.72
Total cholesterol (mmol/L)	4.3±0.28	4.9±0.17	4.29±0.30	4.21±34
HDL (mmol/L)	0.91±0.07^∗	1.08±0.06^Ψ	0.83±0.07^∗	1.5±0.05
LDL (mmol/L)	2.70±0.23	1.90±0.15	2.69±0.27	2.07±0.30
Triglycerides (mmol/L)	1.46±0.21	2.66±0.94^∗	2.1^∗±0.27	1.22±0.17

 ^∗𝑃<0.05 compared to normoglycemic control subjects.
 ^Ψ𝑃<0.05 compared to diabetes with CHD.
SEM: standard error of the mean.